文献速递儿童心血管与肾脏新生儿儿童内分泌与遗传代谢

遗传综合征不影响症状性法洛四联症新生儿生存但增加并发症

Genetic Syndromes Do Not Affect Survival but Increase Morbidity in Neonates with Symptomatic Tetralogy of Fallot.
PubMed 文献 · J Pediatr · 2026-03-10

该多中心回顾性研究纳入572例需新生儿期干预的症状性法洛四联症患儿,其中26.4%存在可识别的遗传诊断。

要点

  • 遗传诊断未显著增加症状性法洛四联症新生儿的死亡风险。
  • 遗传诊断组ICU和总住院时间更长,出院带喂养管风险更高。
  • 遗传检测有助于告知临床医生和家庭相关并发症风险。

核心结论

  • 症状性法洛四联症新生儿中,遗传诊断与无显著生存差异相关,但增加住院时长和出院带喂养管等并发症风险。

研究设计与样本

  • 多中心回顾性研究分析2005至2017年先天性心脏病研究协作组中需新生儿期干预的症状性法洛四联症患者,共572例,遗传诊断从医院记录回顾性收集。

主要发现

  • 572例中151例(26.4%)有可识别遗传诊断,包括22q11缺失63例(41.7%)、21三体28例(18.5%)和其他遗传诊断60例(39.7%)。

临床怎么用

  • 对该人群进行遗传检测可帮助临床医生和家庭预判住院时间延长及出院带喂养管等并发症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess associations between the presence of genetic diagnoses and survival and morbidity of patients with symptomatic tetralogy of Fallot (sTOF) requiring neonatal intervention. STUDY DESIGN: We performed an analysis of a multicenter, retrospective study of sTOF patients from 2005 to 2017 from the Congenital Cardiac Research Collaborative. The primary outcome was transplant-free survival, evaluated by Cox proportional hazards regression modeling, adjusted for center, repair strategy, anatomical diagnosis, prematurity, and invasive ventilation before intervention. Genetic diagnoses were retrospectively collected from hospital records. RESULTS: The study group included 572 neonates with sTOF, of whom 151 (26.4%) had an identifiable genetic diagnosis, including 22q11 deletion (n = 63, 41.7%), trisomy 21 (n = 28, 18.5%), and other genetic diagnoses (n = 60, 39.7%). At a median follow-up of 4.12 (1.53, 7.47) years, there was no significantly increased hazard ratio of death in patients with a genetic diagnosis (adjusted hazard ratio 1.71 [95% CI 0.96-3.07], P = .07). However, patients with a genetic diagnosis had longer median intensive care unit and total hospital stays ([13 vs 9 days, P < .001] and [32.5 vs 24 days, P < .001], respectively) and were more likely to be discharged with feeding tubes (OR 2.1 [95% CI 1.31-3.37], P = .002). CONCLUSIONS: Neonates with sTOF with a genetic diagnosis had no significant survival difference to those without but did have a higher risk for other hospital morbidities, including longer admissions and the need for feeding tubes. Genetic testing in this population can inform clinicians and families regarding these important considerations within this congenital heart disease population.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Nelson JE, Petit CJ, Goldstein BH, et al. Genetic Syndromes Do Not Affect Survival but Increase Morbidity in Neonates with Symptomatic Tetralogy of Fallot. J Pediatr. 2026. PMID: 41812746. doi:10.1016/j.jpeds.2026.115058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。